Got this in an email today ...Monday, 12 February 2024
PME - PRO MEDICUS LIMITED
Macquarie rates PME as Initiation of coverage with Outperform (1) - Macquarie initiates coverage of Pro Medicus with an Outperform rating and a $120 target. Pro Medicus is a provider of healthcare imaging software (Visage 7), with current contracted revenue implying US market share of some 7% in FY25.
US market share has increased in recent years, the broker notes, underpinning strong revenue and earnings growth.
Macquarie sees the competitive advantages of Pro Medicus' product offering as driving market share gains over the medium-longer term, with upside from new products.
Target price is $120.00 Current Price is $106.77 Difference: $13.23 If PME meets the Macquarie target it will return approximately 12% (excluding dividends, fees and charges). Current consensus price target is $75.10, suggesting downside of -29.7%(ex-dividends)The company's fiscal year ends in June.
Forecast for FY24:
Macquarie forecasts a full year FY24 dividend of 39.00 cents and EPS of 77.70 cents . At the last closing share price the estimated dividend yield is 0.37%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 137.41. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 76.5, implying annual growth of 31.7%. Current consensus DPS estimate is 38.7, implying a prospective dividend yield of 0.4%. Current consensus EPS estimate suggests the PER is 139.6.
Forecast for FY25:
Macquarie forecasts a full year FY25 dividend of 49.00 cents and EPS of 97.20 cents . At the last closing share price the estimated dividend yield is 0.46%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 109.85. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 98.9, implying annual growth of 29.3%. Current consensus DPS estimate is 49.4, implying a prospective dividend yield of 0.5%. Current consensus EPS estimate suggests the PER is 108.0.
Market Sentiment: -0.2All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ann: PME launches Visage Ease VP for Apple Vision Pro, page-17
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$131.41 |
Change
-1.810(1.36%) |
Mkt cap ! $13.80B | |||
| Open | High | Low | Value | Volume |
| $133.00 | $133.23 | $130.72 | $15.96M | 120.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 56 | $131.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $131.41 | 10 | 2 |
View Market Depth
| Last trade - 15.02pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$131.35 |
Change
-1.810 ( 1.02 %) |
||||
| Open | High | Low | Volume | ||
| $132.60 | $133.13 | $130.73 | 36547 | ||
| Last updated 15.22pm 14/06/2024 ? | |||||
| PME (ASX) Chart |